By clicking yes you will be able to see content available for healthcare professionals only.
Våre nettsider benytter cookies. Dersom cookien ikke er nødvendig for at nettsiden vår skal fungere,
vil den ikke lagres på din enhet med mindre du samtykker til dette.
Les mer om cookies her.
Ikke satt ennå.
What this seminar is about:Photocure in cooperation with HealthTalk welcomes you to a watch a webinar discussing bladder cancer in these challenging times of COVID-19 with a Nordic perspective. Anders Debes, Chief Medical Officer at Bærum hospital in Norway, together with HealthTalk's Editor in chief Hans Anderssen chair a conversation between:
Together they discussed relevant topics related to the treatment and follow- up of bladder cancer patients during the pandemic.
This is a recording of the seminar which took place 11.06.20.
Anders Debes is Chief Medical Officer at Bærum Hospital and responsible for the contingency plan during the pandemic. He has earlier worked as a urologist at several hospitals in Norway.
Erik Skaaheim Haug is a urologist at Vestfold Hospital in Norway and a researcher at the Department of Cancer Genetics and Informatics, Oslo University Hospital. He has a doctorate on results after surgery for abdominal aortic aneurysm and he is chairman of the Norwegian Urological Cancer Group, of the Norwegian bladder cancer group and of the advisory board of the Norwegian Prostate Cancer Registry.
Tomas Thiel is a urologist at Karolinska University Hospital Stockholm/Huddinge, Sweden. He has a PhD in the field of Bladder Cancer – «Effects of BCG-treatment on urinary bladder cancer with focus on nitric oxide». He is a member of the regional bladder cancer group.
Jørgen Bjerggaard Jensen is a professor and Head of clinical research in bladder cancer and robotic surgery at the Department of Urology, Aarhus University Hospital in Denmark. He is also Chairman of the Nordic Urothelial Cancer Group and Chief of Operation at BLACREST, in addition he is Head of urological research unit at the Department of Urology, Hospital of West Jutland
Mats Bläckberg is a urologist and Senior Consultant at the Department of Urology and Surgery, Helsingborg Hospital in Sweden. Member of SPESAK-group Urothelial cancer since 2001. Member of the board of Examiners, EBU oral exam since 2017. Ongoing research: Investigation of gene expression regarding correlation to treatment and prognosis in bladder cancer.